Laekna, Inc. (2105.HK) Stock Competitors & Peer Comparison
See (2105.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2105.HK | HK$6.73 | -2.60% | 3B | -9.84 | -HK$0.68 | N/A |
| 4332.HK | HK$1,850.00 | +0.00% | 998.5B | 45.81 | HK$40.38 | N/A |
| 6160.HK | HK$195.50 | +2.09% | 260.3B | 87.25 | HK$2.21 | N/A |
| 2269.HK | HK$38.96 | +1.83% | 160.9B | 30.38 | HK$1.28 | N/A |
| 1801.HK | HK$93.05 | +0.59% | 160.4B | 169.46 | HK$0.54 | N/A |
| 6990.HK | HK$516.00 | +2.38% | 119.3B | -253.59 | -HK$2.02 | N/A |
| 9926.HK | HK$99.80 | +6.91% | 87B | -70.52 | -HK$1.34 | N/A |
| 3347.HK | HK$38.40 | +0.52% | 45.6B | 38.42 | HK$0.98 | +0.39% |
| 6821.HK | HK$121.80 | +0.66% | 44.2B | 40.13 | HK$3.05 | +1.22% |
| 1530.HK | HK$17.12 | +1.12% | 42.3B | 4.41 | HK$3.84 | +1.48% |
Stock Comparison
2105.HK vs 4332.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 4332.HK has a market cap of 998.5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 4332.HK trades at HK$1,850.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 4332.HK's P/E ratio is 45.81. In terms of profitability, 2105.HK's ROE is N/A, compared to 4332.HK's ROE of N/A. Regarding short-term risk, 2105.HK is more volatile compared to 4332.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 4332.HK's competition here
2105.HK vs 6160.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6160.HK has a market cap of 260.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6160.HK trades at HK$195.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6160.HK's P/E ratio is 87.25. In terms of profitability, 2105.HK's ROE is N/A, compared to 6160.HK's ROE of +0.12%. Regarding short-term risk, 2105.HK is less volatile compared to 6160.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6160.HK's competition here
2105.HK vs 2269.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2269.HK has a market cap of 160.9B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2269.HK trades at HK$38.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2269.HK's P/E ratio is 30.38. In terms of profitability, 2105.HK's ROE is N/A, compared to 2269.HK's ROE of +0.11%. Regarding short-term risk, 2105.HK is more volatile compared to 2269.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2269.HK's competition here
2105.HK vs 1801.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1801.HK has a market cap of 160.4B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1801.HK trades at HK$93.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1801.HK's P/E ratio is 169.46. In terms of profitability, 2105.HK's ROE is N/A, compared to 1801.HK's ROE of +0.05%. Regarding short-term risk, 2105.HK is less volatile compared to 1801.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1801.HK's competition here
2105.HK vs 6990.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6990.HK has a market cap of 119.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6990.HK trades at HK$516.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6990.HK's P/E ratio is -253.59. In terms of profitability, 2105.HK's ROE is N/A, compared to 6990.HK's ROE of -0.10%. Regarding short-term risk, 2105.HK is less volatile compared to 6990.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6990.HK's competition here
2105.HK vs 9926.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 9926.HK has a market cap of 87B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 9926.HK trades at HK$99.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 9926.HK's P/E ratio is -70.52. In terms of profitability, 2105.HK's ROE is N/A, compared to 9926.HK's ROE of -0.14%. Regarding short-term risk, 2105.HK is less volatile compared to 9926.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 9926.HK's competition here
2105.HK vs 3347.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 3347.HK has a market cap of 45.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 3347.HK trades at HK$38.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 3347.HK's P/E ratio is 38.42. In terms of profitability, 2105.HK's ROE is N/A, compared to 3347.HK's ROE of +0.04%. Regarding short-term risk, 2105.HK is less volatile compared to 3347.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 3347.HK's competition here
2105.HK vs 6821.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6821.HK has a market cap of 44.2B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6821.HK trades at HK$121.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6821.HK's P/E ratio is 40.13. In terms of profitability, 2105.HK's ROE is N/A, compared to 6821.HK's ROE of +0.06%. Regarding short-term risk, 2105.HK is more volatile compared to 6821.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6821.HK's competition here
2105.HK vs 1530.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1530.HK has a market cap of 42.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1530.HK trades at HK$17.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1530.HK's P/E ratio is 4.41. In terms of profitability, 2105.HK's ROE is N/A, compared to 1530.HK's ROE of +0.39%. Regarding short-term risk, 2105.HK is less volatile compared to 1530.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1530.HK's competition here
2105.HK vs 2096.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2096.HK has a market cap of 33.8B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2096.HK trades at HK$13.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2096.HK's P/E ratio is 22.23. In terms of profitability, 2105.HK's ROE is N/A, compared to 2096.HK's ROE of +0.16%. Regarding short-term risk, 2105.HK is more volatile compared to 2096.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2096.HK's competition here
2105.HK vs 2696.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2696.HK has a market cap of 32.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2696.HK trades at HK$59.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2696.HK's P/E ratio is 23.92. In terms of profitability, 2105.HK's ROE is N/A, compared to 2696.HK's ROE of +0.22%. Regarding short-term risk, 2105.HK is less volatile compared to 2696.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2696.HK's competition here
2105.HK vs 1548.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1548.HK has a market cap of 32B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1548.HK trades at HK$15.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1548.HK's P/E ratio is -44.94. In terms of profitability, 2105.HK's ROE is N/A, compared to 1548.HK's ROE of -0.13%. Regarding short-term risk, 2105.HK is less volatile compared to 1548.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1548.HK's competition here
2105.HK vs 1877.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1877.HK has a market cap of 27.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1877.HK trades at HK$19.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1877.HK's P/E ratio is -28.90. In terms of profitability, 2105.HK's ROE is N/A, compared to 1877.HK's ROE of -0.11%. Regarding short-term risk, 2105.HK is more volatile compared to 1877.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 1877.HK's competition here
2105.HK vs 2162.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2162.HK has a market cap of 25.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2162.HK trades at HK$84.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2162.HK's P/E ratio is -41.18. In terms of profitability, 2105.HK's ROE is N/A, compared to 2162.HK's ROE of -0.17%. Regarding short-term risk, 2105.HK is less volatile compared to 2162.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2162.HK's competition here
2105.HK vs 9969.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 9969.HK has a market cap of 21.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 9969.HK trades at HK$14.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 9969.HK's P/E ratio is 32.35. In terms of profitability, 2105.HK's ROE is N/A, compared to 9969.HK's ROE of +0.10%. Regarding short-term risk, 2105.HK is more volatile compared to 9969.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 9969.HK's competition here
2105.HK vs 9606.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 9606.HK has a market cap of 21.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 9606.HK trades at HK$237.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 9606.HK's P/E ratio is -35.01. In terms of profitability, 2105.HK's ROE is N/A, compared to 9606.HK's ROE of -0.97%. Regarding short-term risk, 2105.HK is less volatile compared to 9606.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 9606.HK's competition here
2105.HK vs 2315.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2315.HK has a market cap of 21B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2315.HK trades at HK$51.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2315.HK's P/E ratio is 141.72. In terms of profitability, 2105.HK's ROE is N/A, compared to 2315.HK's ROE of +0.11%. Regarding short-term risk, 2105.HK is less volatile compared to 2315.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2315.HK's competition here
2105.HK vs 9688.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 9688.HK has a market cap of 18B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 9688.HK trades at HK$16.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 9688.HK's P/E ratio is -12.57. In terms of profitability, 2105.HK's ROE is N/A, compared to 9688.HK's ROE of -0.24%. Regarding short-term risk, 2105.HK is more volatile compared to 9688.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 9688.HK's competition here
2105.HK vs 6855.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6855.HK has a market cap of 13.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6855.HK trades at HK$37.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6855.HK's P/E ratio is -11.67. In terms of profitability, 2105.HK's ROE is N/A, compared to 6855.HK's ROE of -1.24%. Regarding short-term risk, 2105.HK is less volatile compared to 6855.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6855.HK's competition here
2105.HK vs 7666.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 7666.HK has a market cap of 13.1B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 7666.HK trades at HK$10.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 7666.HK's P/E ratio is -28.44. In terms of profitability, 2105.HK's ROE is N/A, compared to 7666.HK's ROE of +2.70%. Regarding short-term risk, 2105.HK is less volatile compared to 7666.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 7666.HK's competition here
2105.HK vs 2493.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2493.HK has a market cap of 12.9B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2493.HK trades at HK$23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2493.HK's P/E ratio is -8.69. In terms of profitability, 2105.HK's ROE is N/A, compared to 2493.HK's ROE of -1.81%. Regarding short-term risk, 2105.HK is less volatile compared to 2493.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2493.HK's competition here
2105.HK vs 9887.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 9887.HK has a market cap of 12.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 9887.HK trades at HK$66.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 9887.HK's P/E ratio is -491.15. In terms of profitability, 2105.HK's ROE is N/A, compared to 9887.HK's ROE of -0.10%. Regarding short-term risk, 2105.HK is less volatile compared to 9887.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 9887.HK's competition here
2105.HK vs 2595.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2595.HK has a market cap of 12.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2595.HK trades at HK$37.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2595.HK's P/E ratio is -5.31. In terms of profitability, 2105.HK's ROE is N/A, compared to 2595.HK's ROE of N/A. Regarding short-term risk, 2105.HK is less volatile compared to 2595.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2595.HK's competition here
2105.HK vs 2627.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2627.HK has a market cap of 10.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2627.HK trades at HK$29.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2627.HK's P/E ratio is -44.42. In terms of profitability, 2105.HK's ROE is N/A, compared to 2627.HK's ROE of -2.54%. Regarding short-term risk, 2105.HK is less volatile compared to 2627.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2627.HK's competition here
2105.HK vs 2142.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2142.HK has a market cap of 10.1B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2142.HK trades at HK$12.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2142.HK's P/E ratio is 203.30. In terms of profitability, 2105.HK's ROE is N/A, compared to 2142.HK's ROE of +0.17%. Regarding short-term risk, 2105.HK is less volatile compared to 2142.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2142.HK's competition here
2105.HK vs 2335.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2335.HK has a market cap of 9.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2335.HK trades at HK$33.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2335.HK's P/E ratio is -57.43. In terms of profitability, 2105.HK's ROE is N/A, compared to 2335.HK's ROE of N/A. Regarding short-term risk, 2105.HK is more volatile compared to 2335.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2335.HK's competition here
2105.HK vs 1952.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1952.HK has a market cap of 9B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1952.HK trades at HK$25.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1952.HK's P/E ratio is -5.79. In terms of profitability, 2105.HK's ROE is N/A, compared to 1952.HK's ROE of -0.06%. Regarding short-term risk, 2105.HK is less volatile compared to 1952.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1952.HK's competition here
2105.HK vs 6872.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6872.HK has a market cap of 9B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6872.HK trades at HK$165.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6872.HK's P/E ratio is -49.88. In terms of profitability, 2105.HK's ROE is N/A, compared to 6872.HK's ROE of +0.41%. Regarding short-term risk, 2105.HK is less volatile compared to 6872.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6872.HK's competition here
2105.HK vs 1672.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1672.HK has a market cap of 8.9B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1672.HK trades at HK$8.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1672.HK's P/E ratio is -20.51. In terms of profitability, 2105.HK's ROE is N/A, compared to 1672.HK's ROE of -0.19%. Regarding short-term risk, 2105.HK is less volatile compared to 1672.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1672.HK's competition here
2105.HK vs 6938.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6938.HK has a market cap of 8.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6938.HK trades at HK$52.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6938.HK's P/E ratio is -25.53. In terms of profitability, 2105.HK's ROE is N/A, compared to 6938.HK's ROE of N/A. Regarding short-term risk, 2105.HK is less volatile compared to 6938.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6938.HK's competition here
2105.HK vs 2171.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2171.HK has a market cap of 8.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2171.HK trades at HK$14.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2171.HK's P/E ratio is -76.19. In terms of profitability, 2105.HK's ROE is N/A, compared to 2171.HK's ROE of -0.11%. Regarding short-term risk, 2105.HK is more volatile compared to 2171.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2171.HK's competition here
2105.HK vs 6185.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6185.HK has a market cap of 8.5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6185.HK trades at HK$24.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6185.HK's P/E ratio is -3276.65. In terms of profitability, 2105.HK's ROE is N/A, compared to 6185.HK's ROE of -0.00%. Regarding short-term risk, 2105.HK is more volatile compared to 6185.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6185.HK's competition here
2105.HK vs 2157.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2157.HK has a market cap of 8.5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2157.HK trades at HK$4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2157.HK's P/E ratio is -42.95. In terms of profitability, 2105.HK's ROE is N/A, compared to 2157.HK's ROE of +0.24%. Regarding short-term risk, 2105.HK is less volatile compared to 2157.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2157.HK's competition here
2105.HK vs 2256.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2256.HK has a market cap of 7.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2256.HK trades at HK$10.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2256.HK's P/E ratio is -46.93. In terms of profitability, 2105.HK's ROE is N/A, compared to 2256.HK's ROE of +0.03%. Regarding short-term risk, 2105.HK is less volatile compared to 2256.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2256.HK's competition here
2105.HK vs 2616.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2616.HK has a market cap of 7.5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2616.HK trades at HK$4.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2616.HK's P/E ratio is -19.02. In terms of profitability, 2105.HK's ROE is N/A, compared to 2616.HK's ROE of -0.65%. Regarding short-term risk, 2105.HK is less volatile compared to 2616.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2616.HK's competition here
2105.HK vs 9966.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 9966.HK has a market cap of 7.1B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 9966.HK trades at HK$7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 9966.HK's P/E ratio is 29.50. In terms of profitability, 2105.HK's ROE is N/A, compared to 9966.HK's ROE of -0.06%. Regarding short-term risk, 2105.HK is less volatile compared to 9966.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 9966.HK's competition here
2105.HK vs 6826.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6826.HK has a market cap of 6.8B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6826.HK trades at HK$16.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6826.HK's P/E ratio is 22.81. In terms of profitability, 2105.HK's ROE is N/A, compared to 6826.HK's ROE of +0.04%. Regarding short-term risk, 2105.HK is more volatile compared to 6826.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6826.HK's competition here
2105.HK vs 1779.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1779.HK has a market cap of 6.4B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1779.HK trades at HK$89.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1779.HK's P/E ratio is -32.04. In terms of profitability, 2105.HK's ROE is N/A, compared to 1779.HK's ROE of N/A. Regarding short-term risk, 2105.HK is less volatile compared to 1779.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1779.HK's competition here
2105.HK vs 1477.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1477.HK has a market cap of 5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1477.HK trades at HK$5.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1477.HK's P/E ratio is -26.91. In terms of profitability, 2105.HK's ROE is N/A, compared to 1477.HK's ROE of -0.04%. Regarding short-term risk, 2105.HK is less volatile compared to 1477.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1477.HK's competition here
2105.HK vs 2617.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2617.HK has a market cap of 4.2B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2617.HK trades at HK$11.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2617.HK's P/E ratio is -12.11. In terms of profitability, 2105.HK's ROE is N/A, compared to 2617.HK's ROE of -0.74%. Regarding short-term risk, 2105.HK is less volatile compared to 2617.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2617.HK's competition here
2105.HK vs 1167.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1167.HK has a market cap of 4B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1167.HK trades at HK$5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1167.HK's P/E ratio is -48.72. In terms of profitability, 2105.HK's ROE is N/A, compared to 1167.HK's ROE of -0.18%. Regarding short-term risk, 2105.HK is less volatile compared to 1167.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1167.HK's competition here
2105.HK vs 2591.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2591.HK has a market cap of 3.9B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2591.HK trades at HK$8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2591.HK's P/E ratio is -9.25. In terms of profitability, 2105.HK's ROE is N/A, compared to 2591.HK's ROE of -0.38%. Regarding short-term risk, 2105.HK is less volatile compared to 2591.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2591.HK's competition here
2105.HK vs 2629.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2629.HK has a market cap of 3.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2629.HK trades at HK$12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2629.HK's P/E ratio is -4.53. In terms of profitability, 2105.HK's ROE is N/A, compared to 2629.HK's ROE of N/A. Regarding short-term risk, 2105.HK is less volatile compared to 2629.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2629.HK's competition here
2105.HK vs 3378.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 3378.HK has a market cap of 3.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 3378.HK trades at HK$26.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 3378.HK's P/E ratio is 117.36. In terms of profitability, 2105.HK's ROE is N/A, compared to 3378.HK's ROE of +0.13%. Regarding short-term risk, 2105.HK is more volatile compared to 3378.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 3378.HK's competition here
2105.HK vs 2509.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2509.HK has a market cap of 3.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2509.HK trades at HK$16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2509.HK's P/E ratio is 10.03. In terms of profitability, 2105.HK's ROE is N/A, compared to 2509.HK's ROE of +0.68%. Regarding short-term risk, 2105.HK is more volatile compared to 2509.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2509.HK's competition here
2105.HK vs 6132.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6132.HK has a market cap of 3.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6132.HK trades at HK$48.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6132.HK's P/E ratio is -18.21. In terms of profitability, 2105.HK's ROE is N/A, compared to 6132.HK's ROE of -0.43%. Regarding short-term risk, 2105.HK is less volatile compared to 6132.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6132.HK's competition here
2105.HK vs 3880.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 3880.HK has a market cap of 3.2B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 3880.HK trades at HK$23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 3880.HK's P/E ratio is 25.41. In terms of profitability, 2105.HK's ROE is N/A, compared to 3880.HK's ROE of N/A. Regarding short-term risk, 2105.HK is more volatile compared to 3880.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 3880.HK's competition here
2105.HK vs 6955.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6955.HK has a market cap of 3.1B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6955.HK trades at HK$4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6955.HK's P/E ratio is 505.00. In terms of profitability, 2105.HK's ROE is N/A, compared to 6955.HK's ROE of N/A. Regarding short-term risk, 2105.HK is less volatile compared to 6955.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6955.HK's competition here
2105.HK vs 2659.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2659.HK has a market cap of 2.8B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2659.HK trades at HK$17.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2659.HK's P/E ratio is -11.42. In terms of profitability, 2105.HK's ROE is N/A, compared to 2659.HK's ROE of N/A. Regarding short-term risk, 2105.HK is more volatile compared to 2659.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2659.HK's competition here
2105.HK vs 1873.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1873.HK has a market cap of 2.8B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1873.HK trades at HK$1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1873.HK's P/E ratio is 20.95. In terms of profitability, 2105.HK's ROE is N/A, compared to 1873.HK's ROE of +0.06%. Regarding short-term risk, 2105.HK is less volatile compared to 1873.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1873.HK's competition here
2105.HK vs 2179.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2179.HK has a market cap of 2.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2179.HK trades at HK$5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2179.HK's P/E ratio is -3.41. In terms of profitability, 2105.HK's ROE is N/A, compared to 2179.HK's ROE of -1.37%. Regarding short-term risk, 2105.HK is more volatile compared to 2179.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2179.HK's competition here
2105.HK vs 2480.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2480.HK has a market cap of 2.6B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2480.HK trades at HK$13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2480.HK's P/E ratio is -14.94. In terms of profitability, 2105.HK's ROE is N/A, compared to 2480.HK's ROE of N/A. Regarding short-term risk, 2105.HK is more volatile compared to 2480.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2480.HK's competition here
2105.HK vs 6996.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6996.HK has a market cap of 2.5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6996.HK trades at HK$4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6996.HK's P/E ratio is -9.67. In terms of profitability, 2105.HK's ROE is N/A, compared to 6996.HK's ROE of -0.34%. Regarding short-term risk, 2105.HK is less volatile compared to 6996.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6996.HK's competition here
2105.HK vs 1875.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1875.HK has a market cap of 2.5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1875.HK trades at HK$3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1875.HK's P/E ratio is 314.23. In terms of profitability, 2105.HK's ROE is N/A, compared to 1875.HK's ROE of -0.15%. Regarding short-term risk, 2105.HK is more volatile compared to 1875.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 1875.HK's competition here
2105.HK vs 6681.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6681.HK has a market cap of 2.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6681.HK trades at HK$1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6681.HK's P/E ratio is -14.06. In terms of profitability, 2105.HK's ROE is N/A, compared to 6681.HK's ROE of -1.83%. Regarding short-term risk, 2105.HK is more volatile compared to 6681.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6681.HK's competition here
2105.HK vs 1521.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1521.HK has a market cap of 2.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1521.HK trades at HK$1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1521.HK's P/E ratio is 69.01. In terms of profitability, 2105.HK's ROE is N/A, compared to 1521.HK's ROE of +0.02%. Regarding short-term risk, 2105.HK is more volatile compared to 1521.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 1521.HK's competition here
2105.HK vs 2565.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2565.HK has a market cap of 2.1B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2565.HK trades at HK$7.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2565.HK's P/E ratio is -11.34. In terms of profitability, 2105.HK's ROE is N/A, compared to 2565.HK's ROE of N/A. Regarding short-term risk, 2105.HK is less volatile compared to 2565.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2565.HK's competition here
2105.HK vs 2197.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2197.HK has a market cap of 2B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2197.HK trades at HK$1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2197.HK's P/E ratio is -2.03. In terms of profitability, 2105.HK's ROE is N/A, compared to 2197.HK's ROE of +0.11%. Regarding short-term risk, 2105.HK is less volatile compared to 2197.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2197.HK's competition here
2105.HK vs 6660.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6660.HK has a market cap of 1.8B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6660.HK trades at HK$1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6660.HK's P/E ratio is -2.36. In terms of profitability, 2105.HK's ROE is N/A, compared to 6660.HK's ROE of -0.22%. Regarding short-term risk, 2105.HK is more volatile compared to 6660.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6660.HK's competition here
2105.HK vs 2181.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2181.HK has a market cap of 1.7B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2181.HK trades at HK$0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2181.HK's P/E ratio is -12.18. In terms of profitability, 2105.HK's ROE is N/A, compared to 2181.HK's ROE of +0.44%. Regarding short-term risk, 2105.HK is more volatile compared to 2181.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2181.HK's competition here
2105.HK vs 6622.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6622.HK has a market cap of 1.5B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6622.HK trades at HK$2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6622.HK's P/E ratio is -4.83. In terms of profitability, 2105.HK's ROE is N/A, compared to 6622.HK's ROE of -0.13%. Regarding short-term risk, 2105.HK is more volatile compared to 6622.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6622.HK's competition here
2105.HK vs 2566.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2566.HK has a market cap of 1.4B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2566.HK trades at HK$5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2566.HK's P/E ratio is 9.22. In terms of profitability, 2105.HK's ROE is N/A, compared to 2566.HK's ROE of N/A. Regarding short-term risk, 2105.HK is less volatile compared to 2566.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2566.HK's competition here
2105.HK vs 1541.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1541.HK has a market cap of 1.4B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1541.HK trades at HK$3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1541.HK's P/E ratio is -4.06. In terms of profitability, 2105.HK's ROE is N/A, compared to 1541.HK's ROE of -0.33%. Regarding short-term risk, 2105.HK is less volatile compared to 1541.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1541.HK's competition here
2105.HK vs 2511.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2511.HK has a market cap of 1.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2511.HK trades at HK$2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2511.HK's P/E ratio is -3.79. In terms of profitability, 2105.HK's ROE is N/A, compared to 2511.HK's ROE of -0.39%. Regarding short-term risk, 2105.HK is less volatile compared to 2511.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2511.HK's competition here
2105.HK vs 3681.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 3681.HK has a market cap of 1.3B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 3681.HK trades at HK$1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 3681.HK's P/E ratio is -6.24. In terms of profitability, 2105.HK's ROE is N/A, compared to 3681.HK's ROE of -0.28%. Regarding short-term risk, 2105.HK is less volatile compared to 3681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 3681.HK's competition here
2105.HK vs 2592.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2592.HK has a market cap of 1.2B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2592.HK trades at HK$1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2592.HK's P/E ratio is -1.74. In terms of profitability, 2105.HK's ROE is N/A, compared to 2592.HK's ROE of N/A. Regarding short-term risk, 2105.HK is more volatile compared to 2592.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2592.HK's competition here
2105.HK vs 2898.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2898.HK has a market cap of 1B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2898.HK trades at HK$6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2898.HK's P/E ratio is -10.49. In terms of profitability, 2105.HK's ROE is N/A, compared to 2898.HK's ROE of -0.39%. Regarding short-term risk, 2105.HK is more volatile compared to 2898.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2898.HK's competition here
2105.HK vs 6998.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6998.HK has a market cap of 1B. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6998.HK trades at HK$1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6998.HK's P/E ratio is -3.58. In terms of profitability, 2105.HK's ROE is N/A, compared to 6998.HK's ROE of +0.18%. Regarding short-term risk, 2105.HK is less volatile compared to 6998.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 6998.HK's competition here
2105.HK vs 2487.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2487.HK has a market cap of 948.4M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2487.HK trades at HK$2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2487.HK's P/E ratio is -1.63. In terms of profitability, 2105.HK's ROE is N/A, compared to 2487.HK's ROE of -0.41%. Regarding short-term risk, 2105.HK is more volatile compared to 2487.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2487.HK's competition here
2105.HK vs 1228.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1228.HK has a market cap of 853.9M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1228.HK trades at HK$1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1228.HK's P/E ratio is -3.05. In terms of profitability, 2105.HK's ROE is N/A, compared to 1228.HK's ROE of -0.04%. Regarding short-term risk, 2105.HK is more volatile compared to 1228.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 1228.HK's competition here
2105.HK vs 9939.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 9939.HK has a market cap of 792.4M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 9939.HK trades at HK$1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 9939.HK's P/E ratio is -4.16. In terms of profitability, 2105.HK's ROE is N/A, compared to 9939.HK's ROE of -0.99%. Regarding short-term risk, 2105.HK is less volatile compared to 9939.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 9939.HK's competition here
2105.HK vs 2496.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2496.HK has a market cap of 740.7M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2496.HK trades at HK$3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2496.HK's P/E ratio is -7.24. In terms of profitability, 2105.HK's ROE is N/A, compared to 2496.HK's ROE of +2.42%. Regarding short-term risk, 2105.HK is more volatile compared to 2496.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2496.HK's competition here
2105.HK vs 2137.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2137.HK has a market cap of 728.4M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2137.HK trades at HK$0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2137.HK's P/E ratio is -3.21. In terms of profitability, 2105.HK's ROE is N/A, compared to 2137.HK's ROE of -0.09%. Regarding short-term risk, 2105.HK is more volatile compared to 2137.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2137.HK's competition here
2105.HK vs 2126.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2126.HK has a market cap of 716.3M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2126.HK trades at HK$1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2126.HK's P/E ratio is -1.13. In terms of profitability, 2105.HK's ROE is N/A, compared to 2126.HK's ROE of -0.75%. Regarding short-term risk, 2105.HK is more volatile compared to 2126.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2126.HK's competition here
2105.HK vs 2185.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2185.HK has a market cap of 589.3M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2185.HK trades at HK$2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2185.HK's P/E ratio is -4.02. In terms of profitability, 2105.HK's ROE is N/A, compared to 2185.HK's ROE of -0.15%. Regarding short-term risk, 2105.HK is less volatile compared to 2185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2185.HK's competition here
2105.HK vs 1244.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 1244.HK has a market cap of 523.8M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 1244.HK trades at HK$2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 1244.HK's P/E ratio is -2.57. In terms of profitability, 2105.HK's ROE is N/A, compared to 1244.HK's ROE of -0.27%. Regarding short-term risk, 2105.HK is less volatile compared to 1244.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 1244.HK's competition here
2105.HK vs 2257.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2257.HK has a market cap of 492.2M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2257.HK trades at HK$4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2257.HK's P/E ratio is -3.41. In terms of profitability, 2105.HK's ROE is N/A, compared to 2257.HK's ROE of +1.92%. Regarding short-term risk, 2105.HK is less volatile compared to 2257.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2105.HK.Check 2257.HK's competition here
2105.HK vs 0690.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 0690.HK has a market cap of 489.6M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 0690.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 0690.HK's P/E ratio is 6.10. In terms of profitability, 2105.HK's ROE is N/A, compared to 0690.HK's ROE of +0.23%. Regarding short-term risk, 2105.HK is more volatile compared to 0690.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 0690.HK's competition here
2105.HK vs 6628.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6628.HK has a market cap of 460.3M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6628.HK trades at HK$1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6628.HK's P/E ratio is -0.76. In terms of profitability, 2105.HK's ROE is N/A, compared to 6628.HK's ROE of -0.32%. Regarding short-term risk, 2105.HK is more volatile compared to 6628.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6628.HK's competition here
2105.HK vs 2396.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 2396.HK has a market cap of 323.8M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 2396.HK trades at HK$3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 2396.HK's P/E ratio is -1.62. In terms of profitability, 2105.HK's ROE is N/A, compared to 2396.HK's ROE of N/A. Regarding short-term risk, 2105.HK is more volatile compared to 2396.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 2396.HK's competition here
2105.HK vs 6978.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 6978.HK has a market cap of 267M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 6978.HK trades at HK$0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 6978.HK's P/E ratio is -1.34. In terms of profitability, 2105.HK's ROE is N/A, compared to 6978.HK's ROE of +2.93%. Regarding short-term risk, 2105.HK is more volatile compared to 6978.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 6978.HK's competition here
2105.HK vs 8158.HK Comparison July 2026
2105.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2105.HK stands at 3B. In comparison, 8158.HK has a market cap of 79.1M. Regarding current trading prices, 2105.HK is priced at HK$6.73, while 8158.HK trades at HK$0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2105.HK currently has a P/E ratio of -9.84, whereas 8158.HK's P/E ratio is -0.71. In terms of profitability, 2105.HK's ROE is N/A, compared to 8158.HK's ROE of +0.67%. Regarding short-term risk, 2105.HK is more volatile compared to 8158.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2105.HK.Check 8158.HK's competition here